|
Advocate Spot-on šķīdums gigantiskiem suņiem
|
-
|
EU/2/03/039/018
|
Bayer Animal Health , Vācija
|
QP54AB52
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Moxidectin,Imidacloprid
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
KVP Pharma + Veterinar Produkte GmbH, Vācija
|
| Date of authorisation/renewal: |
01-Apr-2003
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/03/039/018 |
|
4 |
Pipete, 4 ml |
-
|
|
|
Melovem
|
20 mg/ml
|
EU/2/09/098/002
|
Dopharma Research B.V., Nīderlande
|
QM01AC06
|
cattle; pigs; horses
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Meloxicam
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Dopharma B.V., Nīderlande
|
| Date of authorisation/renewal: |
06-Jun-2014
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/09/098/002 |
20 mg/ml |
1 |
Stikla flakons, 50 ml |
-
|
|
|
Fluralaner Intervet
|
200 mg
|
EU/2/25/346/009
|
Intervet International B.V., Nīderlande
|
QP53BE02
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Fluralaner
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
27-Jun-2025
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/25/346/009 |
|
1 |
Blisteris, 1 tablete |
-
|
|
|
APOQUEL
|
3.6 mg
|
EU/2/13/154/021
|
Zoetis Belgium S.A., Beļģija
|
QD11AH90
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
film-coated tablets
|
| International name (active substance): |
Oclacitinib
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Zoetis Belgium S.A., Beļģija;Pfizer Italia S.R.L., Itālija
|
| Date of authorisation/renewal: |
13-Dec-2021
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/13/154/021 |
3,6 mg |
10 |
Blisteris, 10 tablete |
-
|
|
|
UpCard
|
0.75 mg
|
EU/2/15/184/002
|
Vetoquinol S.A., Francija
|
QC03CA04
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Torasemide
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Vetoquinol S.A., Francija
|
| Date of authorisation/renewal: |
24-Jun-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/15/184/002 |
0,75 mg |
10 |
PVH/PHTFE alumīnija blisteris, 10 tablete |
-
|
|
|
Vectormune FP ILT
|
-
|
EU/2/20/266/004
|
Ceva-Phylaxia Veterinary Biologicals Co. Ltd., Ungārija
|
-
|
chickens
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate and solvent for suspension for injection
|
| International name (active substance): |
Live recombinant fowlpox virus
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Ceva-Phylaxia Veterinary Biologicals Co. Ltd., Ungārija
|
| Date of authorisation/renewal: |
09-Dec-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/20/266/004 |
|
5 |
Stikla flakons, 2000 devas/flakonā |
-
|
|
|
Daxocox
|
70 mg
|
EU/2/21/270/047
|
Ecuphar NV, Beļģija
|
QM01AH95
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Enflicoxib
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Lelypharma B.V., Nīderlande
|
| Date of authorisation/renewal: |
19-Dec-2024
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/21/270/047 |
|
1 |
Blisteris, 5 tablete |
-
|
|
|
Imoxat
|
250 mg
|
EU/2/21/280/005
|
Chanelle Pharmaceuticals Manufacturing Limited, Īrija
|
QP54AB52
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Imidacloprid, Moxidectin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
|
| Date of authorisation/renewal: |
07-Dec-2021
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/21/280/005 |
|
3 |
Pipete, 2,5 ml |
-
|
|
|
Numelvi
|
4.8 mg
|
EU/2/25/351/002
|
Intervet International B.V., Nīderlande
|
QD11AH93
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Atinvicitinib
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
24-Jul-2025
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/25/351/002 |
4,8 mg/tabl. |
3 |
Blisteris, 30 tablete |
-
|
|
|
Lotilaner Elanco
|
900 mg
|
EU/2/22/288/009
|
Elanco GmbH, Vācija
|
QP53BE04
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Lotilaner
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Elanco France S.A.S., Francija
|
| Date of authorisation/renewal: |
13-Sep-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/22/288/009 |
900 mg |
1 |
Blisteris, 1 tablete |
-
|
|
|
Porcilis Porcoli Diluvac Forte
|
-
|
EU/2/96/001/005
|
Intervet International Booxmer, Nīderlande
|
QI09AB02
|
pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
F4ab (K88ab) fimbrial adhesin,F5 (K99) fimbrial adhesin,LT toxoid,F4ac (K88ac) fimbrial adhesin,F6 (987P) fimbrial adhesin
|
| Distribution category: |
To be used only by veterinary surgeon
|
| Manufacturer(s) responsible for batch release |
Intervet International Booxmer, Nīderlande
|
| Date of authorisation/renewal: |
10-Apr-2006
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/96/001/005 |
|
1 |
Flakons, 100 ml |
-
|
|
|
Melovem
|
30 mg/ml
|
EU/2/09/098/007
|
Dopharma Research B.V., Nīderlande
|
QM01AC06
|
cattle; pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Meloxicam
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Dopharma B.V., Nīderlande
|
| Date of authorisation/renewal: |
06-Jun-2014
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/09/098/007 |
30 mg/ml |
1 |
Stikla flakons, 250 ml |
-
|
|
|
Nobilis Multriva Gm+REOm
|
-
|
EU/2/25/344/001
|
Intervet International B.V., Nīderlande
|
QI01AA22
|
chickens
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
emulsion for injection
|
| International name (active substance): |
Infectious bursal disease virus, strain GB02, Inactivated
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
02-Jun-2025
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/25/344/001 |
|
1 |
PET pudele, 300 ml |
-
|
|
|
LEUCOFELIGEN FeLV/RCP
|
-
|
EU/2/09/097/001
|
VIRBAC, Francija
|
QI06AH07
|
cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate and solvent for suspension for injection
|
| International name (active substance): |
Live feline calicivirus, strain F9,Live Panleucopenia virus LR72 strain
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
VIRBAC, Francija
|
| Date of authorisation/renewal: |
06-Jun-2014
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/09/097/001 |
|
10 |
Flakons, 1 deva |
-
|
|
|
Evanovo
|
-
|
EU/2/22/284/006
|
Laboratorios Hipra S.A., Spānija
|
QI01AN01
|
embryonated chicken eggs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension and solvent for suspension for injection
|
| International name (active substance): |
Eimeria acervulina, strain 044, Eimeria maxima, strain 013, Eimeria praecox, strain 007, Eimeria tenella, strain 004
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Laboratorios Hipra S.A., Spānija
|
| Date of authorisation/renewal: |
27-Jul-2022
|
| Marketing authorisation valid until: |
26-Jul-2027
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/22/284/006 |
|
1 |
Stikla flakons, 10000 deva |
-
|
|
|
Bravecto
|
250 mg
|
EU/2/13/158/020
|
Intervet International B.V., Nīderlande
|
QP53B
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Fluralaner
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Intervet UK Ltd, Lielbritānija
|
| Date of authorisation/renewal: |
13-Feb-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/13/158/020 |
250 mg |
1 |
Pipete, 1 deva |
-
|
|
|
EVICTO
|
120 mg
|
EU/2/19/242/016
|
VIRBAC, Francija
|
QP54AA05
|
dogs 10,1–20,0 kg
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Selamectin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
VIRBAC, Francija
|
| Date of authorisation/renewal: |
19-Jul-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/19/242/016 |
120 mg/ml |
1 |
Polipropilēna pipete, 1 ml |
-
|
|
|
Lotilaner/Milbemycin Elanco 225 mg/8,44 mg
|
-
|
EU/2/26/361/012
|
Elanco GmbH, Vācija
|
QP54AB51
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Lotilaner, Milbemycin oxime
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Elanco France S.A.S, Francija
|
| Date of authorisation/renewal: |
25-Feb-2026
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/26/361/012 |
|
18 |
Al/Al blisteris, 1 tablete |
-
|
|
|
Bluevac BTV8
|
-
|
EU/2/11/122/002
|
C.Z. Veterinaria, Spānija
|
QI04AA02
|
cattle; sheep
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Bluetongue virus serotype 8 antigen
|
| Distribution category: |
To be used only by veterinary surgeon
|
| Manufacturer(s) responsible for batch release |
C.Z. Veterinaria, Spānija
|
| Date of authorisation/renewal: |
13-Apr-2016
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/11/122/002 |
|
1 |
Flakons, 50 deva |
-
|
|
|
Firocoxib CP-Pharma
|
57 mg
|
EU/2/25/359/004
|
CP-Pharma Handelsgesellschaft GmbH, Vācija
|
QM01AH90
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Firocoxib
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
CP-Pharma Handelsgesellschaft GmbH, Vācija
|
| Date of authorisation/renewal: |
26-Jan-2026
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/25/359/004 |
|
50 |
alumīnija/PVC/PE/PVDC blisteris, 10 tablete |
-
|
|